Hebes Life Science

👥 13 employees💰 Last funded Nov 2024
Pharmaceutical Manufacturing
LinkedIn
Hebe Life Science is a pioneering biotechnology pharmaceutical company in Latin America, committed to developing safe and effective solutions in healthcare. We are the first company in Latin America to produce type A botulinum toxin, in addition to injectable hyaluronic acid and biostimulators, offering excellent products to meet the needs of the therapeutic, medical, and aesthetic markets. - Hebe Life Science é uma farmacêutica biotecnológica pioneira na América Latina, comprometida com o desenvolvimento de soluções seguras e eficazes na área da saúde. Somos a primeira empresa na América Latina a produzir toxina botulínica tipo A, além de ácido hialurônico injetável e bioestimuladores, oferecendo produtos de excelência para atender às necessidades dos mercados terapêutico, médico e estético.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Brazil
1
Frequently asked questions
Who invested in Hebes Life Science?
Hebes Life Science has 1 investors on record on gritt.io.
When did Hebes Life Science last raise funding?
The most recent investment in Hebes Life Science recorded on gritt.io was in November 2024.
What industry is Hebes Life Science in?
Hebes Life Science operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.